Abstract:We present an unusual case of a patient with bilateral-lung transplantation due to severe coronavirus disease 2019 (COVID-19), who subsequently suffered complications with acute myocardial infarction and underwent primary percutaneous coronary intervention (PCI). A 70-year-old man presented with fever, cough, and dyspnea after returning from Hubei Province at the end of Jan. 2020. The diagnosis of COVID-19 had been confirmed by the nucleic acid test at a local hospital on Feb. 2, 2020. He had a history of mild hypertension and Type 2 diabetes without regular medication. He was a current smoker but denied the history of ischemic heart disease or hyperlipidemia. Despite initial treatment with methylprednisolone, umifenovir, and darunavir, the patient’s condition worsened with continued dyspnea and persisting fever. On Feb. 9 (Day 7 after symptoms onset), the patient was transferred to the intensive care unit (ICU) of our hospital. On arrival, the patient’s vital signs were stable except for tachypnoea at 27 min. Key laboratory results were: white blood cell count, 6.6×10 L; neutrophil, 89.1%; hemoglobin, 129 g/L; platelet count, 180×10 L; creatinine, 64 μmol/L; high sensitive C reaction protein (hs-CRP), 45.51 mg/L. chest computed tomography (CT) scan showed bilateral diffuse infiltration. After admission, he was treated with high-flow nasal oxygen, methylprednisolone, umifenovir, piperacillin, and tazobactam. On Feb. 14 (Day 12), he was intubated due to severe hypoxia. On Feb. 22 (Day 20), repeated nucleic acid tests for 2019 novel coronavirus (2019-nCoV) in sputum and bronchoalveolar lavage fluid were all negative; however, his condition continued to deteriorate due to pulmonary consolidation complicated by Stenotrophomonas maltophilia infection. We began venovenous extracorporeal membrane oxygenation (ECMO) treatment on Feb. 26 (Day 24). A CT scan on Mar. 2 (Day 29) revealed significant progression of pulmonary consolidation (Fig. 1). A bilateral-lung transplantation was performed on Mar. 8 (Day 34) after multidisciplinary discussion. Postoperatively, the ECMO was withdrawn since the oxygenation had been improved and the patient’s general condition was more stable. A continuous renal replacement therapy (CRRT) was started on Mar. 10 (Day 36/Day 2 postoperative) to support renal function. On Mar. 11 (Day 3 postoperative), laboratory results were: hemoglobin, 80 g/L; platelet count, 36×10 L; creatinine, 103 μmol/L; international normalized ratio (INR), 1.77; activated partial thromboplastin time (APTT), 45.9 s; prothrombin time (PT), 20.8 s; D-dimer, 2927.00 μg/L. On Mar. 12 at 9:00 a.m. (Day 4 postoperative), the patient developed a sudden episode of ventricular fibrillation. After cardiopulmonary resuscitation with Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology) ISSN 1673-1581 (Print); ISSN 1862-1783 (Online) www.jzus.zju.edu.cn; www.springerlink.com E-mail: jzus@zju.edu.cn

Myocardial Infarction Detected by a Smartwatch after Transcatheter Aortic Valve Replacement During the COVID-19 Pandemic

Smartwatch Facilitated Remote Health Care for Patients Undergoing Transcatheter Aortic Valve Replacement Amid COVID-19 Pandemic

Wearable Smartwatch Facilitated Remote Health Management for Patients Undergoing Transcatheter Aortic Valve Replacement

Primary Percutaneous Coronary Intervention in a COVID-19 Patient with ST-segment Elevation Myocardial Infarction after Lung Transplantation: a Case Report

Anterior wall myocardial infarction in a 16-year-old man caused by coronary artery aneurysm during the outbreak of COVID-19

Wearable smartwatch monitoring arrhythmias for patients who at high risk of pacemaker implantation after transcatheter aortic valve replacement

The value of smart watch in diagnosis of atrial fibrillation and left bundle branch block after transcatheter aortic valve replacement

Ambulatory Smartwatch ECG Monitoring among Patients Undergoing Transcatheter Aortic Valve Replacement Early after Discharge: an Observational Study

Smartwatch-Detected Arrhythmias in Patients After Transcatheter Aortic Valve Replacement (TAVR): Analysis of the SMART TAVR Trial

Delayed presentation of acute coronary syndrome with mechanical complication during COVID-19 pandemic: a case report

Simultaneous Double-Vessel Coronary Thrombosis with Sudden Cardiac Arrest as the First Manifestation of COVID-19

Early myopericarditis diagnosed in a 31-year-old patient using smartwatch technology: A case report

Prehospital ECG in patients with acute myocardial infarction during the COVID-19 pandemic

Changes in the investigation and management of suspected myocardial infarction and injury during COVID-19: a multi-centre study using routinely collected healthcare data

The Impact of COVID-19 on Short-Term Prognosis of ST-segment Elevation Myocardial Infarction Patients Receiving Primary Percutaneous Coronary Intervention in Wuhan China

Acute Myocardial Injury is Common in Patients with COVID-19 and Impairs Their Prognosis

Initial Findings From the North American COVID-19 Myocardial Infarction Registry

Myocardial Injury by COVID-19 Infection Assessed by Cardiovascular Magnetic Resonance Imaging - A Prospective Multicenter Study

Recommendation to Use Wearable-Based mHealth in Closed-Loop Management of Acute Cardiovascular Disease Patients During the COVID-19 Pandemic

COVID-19 Infection and ST-Elevation Myocardial Infarction: Lessons in Disease Management During a Pandemic

Transcatheter aortic valve implantation versus surgical aortic valve replacement during the COVID‐19 pandemic—Current practice and concerns